Reply: Inotropes and Mortality

As underscored throughout our paper, we strongly agree that published studies have failed to provide adequate information comparing the risks and benefits of intravenous inotropes used in a range of ambulatory patients with advanced heart failure [(1)][1]. The goal of our review was to summarize the